Cantor Fitzgerald Maintains Overweight Rating for Nano X Imaging: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Cantor Fitzgerald has maintained its Overweight rating on Nano X Imaging (NASDAQ:NNOX) but reduced its price target from $24.00 to $18.00. Despite the reduction, the new target suggests a significant upside of 213.04% from the current price of $5.75. Nano X Imaging is involved in manufacturing medical imaging systems, including the Nanox System and Nanox.CLOUD software.
January 19, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald reaffirmed its Overweight rating on Nano X Imaging but lowered the price target to $18, indicating a potential upside of 213.04% from the current price.
The maintenance of an Overweight rating by Cantor Fitzgerald suggests a positive outlook on Nano X Imaging, while the price target reduction might reflect adjustments in market conditions or company valuation. However, the substantial potential upside indicated by the new price target could drive investor interest and potentially increase the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100